Evidence map›Paper›PMID 31780702›Full record

ArticleScientific reports2019

Maria Cristina Cardia, Carla Caddeo, Francesco Lai, Anna Maria Fadda, Chiara Sinico, Michel Luhmer

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Comparative Study on Curcumin Loaded in Golden Pompano (Molecules (Basel, Switzerland) · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Maria Cristina CardiaDipartimento di Scienze della Vita e dell'Ambiente, Sezione di Scienze del Farmaco, University of Cagliari, CNBS, Via Ospedale 72, 09124, Cagliari, Italy.ORCID http://orcid.org/0000-0002-2788-7823
Carla CaddeoDipartimento di Scienze della Vita e dell'Ambiente, Sezione di Scienze del Farmaco, University of Cagliari, CNBS, Via Ospedale 72, 09124, Cagliari, Italy.
Francesco LaiDipartimento di Scienze della Vita e dell'Ambiente, Sezione di Scienze del Farmaco, University of Cagliari, CNBS, Via Ospedale 72, 09124, Cagliari, Italy.
Anna Maria FaddaDipartimento di Scienze della Vita e dell'Ambiente, Sezione di Scienze del Farmaco, University of Cagliari, CNBS, Via Ospedale 72, 09124, Cagliari, Italy.
Chiara SinicoDipartimento di Scienze della Vita e dell'Ambiente, Sezione di Scienze del Farmaco, University of Cagliari, CNBS, Via Ospedale 72, 09124, Cagliari, Italy. sinico@unica.it.
Michel LuhmerLaboratoire de Résonance Magnétique Nucléaire Haute Résolution, Service de Chimie et PhysicoChimie Organiques, Université libre de Bruxelles (ULB), Avenue F. D. Roosevelt 50, CP160/08, 1050, Brussels, Belgium. mluhmer@ulb.ac.be.ORCID http://orcid.org/0000-0002-4089-6644
University of Cagliari · ITUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resveratrol (RSV) is a well-known natural derivative with a wide range of biological and pharmacological activities. Despite of these demonstrated properties, it exhibits low both aqueous solubility and chemical stability and therefore low bioavailability. Consequently, the major concern of the technological research is to exploit delivery systems able to overcome bioavailability problems. In the recent past liposomes have been successfully studied for these purposes. In this paper,

Indexed as

AntioxidantsGlycine maxLiposomesPhosphatidylcholinesProton Magnetic Resonance SpectroscopyResveratrolAntioxidantsLiposomesPhosphatidylcholinesResveratrol

Identifiers

PMID31780702
PMCPMC6883048
OpenAlexW2990798788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.